<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>RWE | CSE Tracker</title>
    <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20210427rwe/</link>
      <atom:link href="https://master--youthful-lamport-190a0e.netlify.app/tag/20210427rwe/index.xml" rel="self" type="application/rss+xml" />
    <description>RWE</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 27 Apr 2021 08:00:00 -0700</lastBuildDate>
    <image>
      <url>https://master--youthful-lamport-190a0e.netlify.app/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>RWE</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20210427rwe/</link>
    </image>
    
    <item>
      <title>Target Trial Emulation using Real World Data: A Head-to-Head Comparison of Antihyperglycemic Therapies for Type 2 Diabetes</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210427target-trial-emulation-using-real-world-data-a-head-to-head-comparison-of-antihyperglycemic-therapies-for-type-2-diabetes/</link>
      <pubDate>Tue, 27 Apr 2021 08:00:00 -0700</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20210427target-trial-emulation-using-real-world-data-a-head-to-head-comparison-of-antihyperglycemic-therapies-for-type-2-diabetes/</guid>
      <description>&lt;p&gt;During the webinar Alind will discuss:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;p&gt;When a randomized trial to compare effectiveness of healthcare interventions can be emulated using real-world data.&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;The target trial framework, which couples causal inference methods to an explicit causal question posed in the form of a protocol for a randomized trial.&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;How this approach helps to avoid common methodological pitfalls encountered in na√Øve analyses of observational data.&lt;/p&gt;
&lt;/li&gt;
&lt;/ul&gt;</description>
    </item>
    
    <item>
      <title>Non-Randomized Studies and Utilization of Real-World Evidence</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20201217non-randomized-studies-and-utilization-of-real-world-evidence/</link>
      <pubDate>Thu, 17 Dec 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20201217non-randomized-studies-and-utilization-of-real-world-evidence/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Annual Real World Evidence Conference: Applying Lessons Learned from RWE in the Time of COVID-19 to the Future</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/conference/20201001annual-real-world-evidence-conference-applying-lessons-learned-from-rwe-in-the-time-of-covid-19-to-the-future/</link>
      <pubDate>Thu, 01 Oct 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/conference/20201001annual-real-world-evidence-conference-applying-lessons-learned-from-rwe-in-the-time-of-covid-19-to-the-future/</guid>
      <description>&lt;p&gt;COVID-19 has disrupted the evidence-generation paradigm, resulting in the expanded use of novel technologies, data, and evidence. These new advancements not only improve clinical care and medical product development to fight the pandemic, but also have the potential to inform the future of drug development more broadly. This meeting will explore how COVID-19 has accelerated decision-maker understanding and use of real-world data (RWD) and real-world evidence (RWE) and its application in a post-COVID-19 environment.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Head-to-Head Comparison Using Real-World Data: Study Design Considerations and an Update on the Pilot Investigation in Cancer</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200922study-design-considerations-and-an-update-on-the-pilot-investigation-in-cancer/</link>
      <pubDate>Tue, 22 Sep 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200922study-design-considerations-and-an-update-on-the-pilot-investigation-in-cancer/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Head-to-head Comparisons using Real-World Data: Design and Data Source Considerations from Pilot Investigations in Cardiovascular Disease</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200728design-and-data-source-considerations-from-pilot-investigations-in-cardiovascular-disease/</link>
      <pubDate>Tue, 28 Jul 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200728design-and-data-source-considerations-from-pilot-investigations-in-cardiovascular-disease/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Head-to-Head Comparisons using Real World Data: The Time for Causal Inference is Now</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200707the-time-for-causal-inference-is-now/</link>
      <pubDate>Tue, 07 Jul 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20200707the-time-for-causal-inference-is-now/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
